Evaluation of covered metallic stents in malignant biliary stenosis - Prominent effectiveness in gallbladder carcinoma

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1351-1356

  Kawamoto, Hirofumi ^a   Ishida, E ^a   Okamoto, Y ^a   Okada, H ^a   Sakaguchi, K ^a   Nakagawa, M ^b   Sugihara, T ^b   Shiratori, Y ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

Covered metallic stent; Malignant biliary stenosis

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; METAL; POLYURETHAN; TETRAHYDROFURAN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DEVICE; DISEASE COURSE; ENDOPROSTHESIS LOOSENING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; INOPERABLE CANCER; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT BILIARY STENOSIS; MATERIAL COATING; OUTCOMES RESEARCH; PANCREAS CARCINOMA; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT; SURVIVAL TIME;

ADULT; AGED; BILE DUCT NEOPLASMS; CHOLESTASIS; COMBINED MODALITY THERAPY; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; QUALITY OF LIFE; STENTS; SURVIVAL ANALYSIS;

EID: 25844499184     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Munoz L, Roayaie S, Maman D, et al: Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobil Pancreat Surg 2002; 9:237-241.
2. Martin RC 2nd, Vitale GC, Reed DN, et al: Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma. Surg Endosc 2002; 164:667-670.
3. Wakai T, Shirai Y, Hatakeyama K: Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy. World J Surg 2002; 26:867-871.
4. Kedra B, Popiela T, Sierzega M, et al: Prognostic factors of long-term survival after resective procedures for pancreatic cancer. Hepatogastroenterology 2001; 48:1762-1766.
5. Azria D, Ychou M, Jacot W, et al: Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-Fluorouracil and Cisplatin. Pancreas 2002; 25:360-365.
6. Takada T, Amano H, Yasuda H, et al: Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002; 95:1685-1695.
7. Neri B, Cini G, Doni L, et al: Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study. Br J Cancer 2002; 87:497-501.
8. Ducreux M, Rougier P, Pignon JP, et al: A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Ann Oncol 2002; 13:1185-1191.
9. Colucci G, Giuliani F, Gebbia V, et al: Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale. Cancer 2002; 94:902-910.
10. Taieb J, Mitry E, Boige V, et al: Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol 2002; 13:1192-1196.
11. van Heek NT, van Geenen RC, Busch OR, et al: Palliative treatment in "peri"-pancreatic carcinoma: stenting or surgical therapy? Acta Gastroenterol Belg 2002; 65:171-175.
12. Maosheng D, Ohtsuka T, Ohuchida J, et al: Surgical bypass versus metallic stent for unresectable pancreatic cancer. J Hepatobil Pancreat Surg 2001; 8:367-373.
13. Beissert M, Wittenberg G, Sandstede J, et al: Metallic stents and plastic endoprostheses in percutaneous treatment of biliary obstruction. (German) Z Gastroenterol 2002; 40:503-510.
14. Davids PHP, Groen AK, Rauws EAJ, et al: Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340:1488-1492.
15. Kawase Y: Implantation of metallic stents for malignant biliary stricture: comparison of covered and uncovered stents. Endosc Dig 1998; 10:827-834.
16. Isayama H, Komatsu Y, Tsujino T, et al: Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc 2002; 55:366-370.
17. Schoder M, Rossi P, Uflacker R, et al: Malignant biliary obstruction: Treatment with ePTFE-FEP-covered endoprostheses - Initial technical and clinical experiences in a multicenter trial. Radiology 2002; 225:36-42.
18. Hausegger KA, Thurnher S, Bodendorfer G, et al: Treatment of malignant biliary obstruction with polyurethane-covered Wallstents. Am J Roentgenol 1998; 170:403-408.
19. Rossi P, Bezzi M, Salvatori FM, et al: Clinical experience with covered wallstents for biliary malignancies: 23-month follow-Up. Cardiovasc Intervent Radiol 1997; 20:441-447.
20. Born P, Neuhaus H, Rosch T, et al: Initial experience with a new, partially covered Wallstent for malignant biliary obstruction. Endoscopy 1996; 28:699-702.
21. Sobin LH, Wittekind C (Eds.): International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th Edition. New York: John Wiley & Sons, Inc., 1997.
22. Miyayama S, Matsui O, Terayama N, et al: Covered gianturco stents for malignant biliary obstruction: preliminary clinical evaluation. J Vasc Interv Radiol 1997; 8:641-648.
23. Kanasaki S, Furukawa A, Kane T, et al: Polyurethane-covered Nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc Intervent Radiol 2000; 23:114-120.
24. Nakamura T, Hirai R, Kitagawa M, et al: Treatment of common bile duct obstruction by pancreatic cancer using various stents: Single-center experience. Cardiovasc Intervent Radiol 2002; 25:373-380.
25. Hejna M, Zielinski CC: Nonsurgical management of gall-bladder cancer: cytotoxic treatment and radiotherapy. Expert Rev Anticancer Ther 2001; 1:291-300. (Review)